TF information
| TF name: | JUN |
| TF family: | TF_bZIP |
| Ensembl gene ID: | ENSG00000177606 |
| Ensembl protein ID: | ENSP00000360266 |
| Entrez gene ID: | 3725 |
| Database name | Link | Database name | Link |
| NCBI Gene: |  |
Genecards: |  |
| Uniprot: |  |
Wikipedia: |  |
| Cosmic 3D: |  |
Geneontology: |  |
| CCLE: |  |
Frequency of JUN in all biosamples
| Sample ID | Biosample type | Tissue type | Biosample name | TF Frequency |
|---|---|---|---|---|
| Sample_02_007 | Other | Cervical | cervical-cancer_vector | 0.44370860927152 |
| Sample_02_021 | Cell line | Colon | V429 | 0.68550014413376 |
| Sample_02_164 | Cell line | Lung | H2087_Parental | 0.48333333333333 |
| Sample_02_168 | Cell line | Prostate | LNCaP | 0.35361216730038 |
| Sample_02_179 | Cell line | Urinary bladder | T24 | 0.4367816091954 |
| Sample_02_237 | Cell line | Colon | V389 | 0.093244984354868 |
| Sample_02_242 | Cell line | Colon | V481 | 0.10796000769083 |
| Sample_02_307 | Cell line | Neuroblastoma | SJNB12 | 0.23943661971831 |
| Sample_02_308 | Cell line | Neuroblastoma | SJNB1 | 0.21875 |
| Sample_02_317 | Cell line | Neuroblastoma | GICAN | 0.27027027027027 |
| Sample_02_323 | Cell line | Colon | RKO | 1 |
| Sample_02_355 | Cell line | Colon | HCT15 | 0.22619047619048 |
| Sample_02_395 | Cell line | Mammary Gland | BT-549 | 0.21090909090909 |
JUN distribution in samples’ most representative CRC
| Sample ID | Tissue type | Biosample type | Biosample name |
|---|---|---|---|
| Sample_02_007 | Cervical | Other | cervical-cancer_vector |
| Sample_02_021 | Colon | Cell line | V429 |
| Sample_02_179 | Urinary bladder | Cell line | T24 |
| Sample_02_323 | Colon | Cell line | RKO |
JUN distribution in all CRCs
Genomic distribution of SEs associated with JUN
Genomic distribution of SEs associated with TF
Figure legend:
Genomic distribution of SEs associated with TF: It can roughly understand the genomic regions of SEs associated with TF, and help to carry out the next analysis, such as knocking down the experiment.
What is important information?
The yellow box can be thought of as the common genomic regions that regulates the SEs associated with TF. For example, if a knockdown experiment is performed on this region, then theoretically, the expression of the TF will be greatly reduced.
| Database name | Link |
|---|---|
| Cosmic: |  |
| Cosmic cell lines: |  |
| Depmap: |  |
TCGA somatic mutations and clinical variants of JUN
| rsID | Chr | Start | Stop | Ref | Alt | Gene_region | Gene_symble | Effect | TCGA_Occurrence |
|---|---|---|---|---|---|---|---|---|---|
| - | chr1 | 59247909 | 59247909 | G | C | exonic | JUN | synonymous | KIPAN|1|799|0.00125,KIRC|1|451|0.00222 |
| - | chr1 | 59248515 | 59248515 | - | G | exonic | JUN | frameshift | ESCA|1|185|0.00541 |
| - | chr1 | 59248705 | 59248705 | G | T | exonic | JUN | nonsynonymous | KIPAN|1|799|0.00125,KIRC|1|451|0.00222 |
| - | chr1 | 59248091 | 59248091 | G | A | exonic | JUN | stopgain | PCPG|1|184|0.00543 |
| - | chr1 | 59248409 | 59248409 | C | G | exonic | JUN | nonsynonymous | LUSC|1|178|0.00562 |
| rs749502446 | chr1 | 59248693 | 59248693 | G | A | exonic | JUN | nonsynonymous | THCA|1|504|0.00198 |
| - | chr1 | 59248634 | 59248634 | T | - | exonic | JUN | frameshift | STAD|1|395|0.00253,STES|1|395|0.00253 |
| - | chr1 | 59248625 | 59248625 | G | T | exonic | JUN | nonsynonymous | STAD|1|395|0.00253,STES|1|395|0.00253 |
| - | chr1 | 59247776 | 59247776 | T | C | exonic | JUN | nonsynonymous | LIHC|1|373|0.00268 |
| - | chr1 | 59248487 | 59248487 | C | A | exonic | JUN | nonsynonymous | LUAD|2|543|0.00368 |
| - | chr1 | 59247973 | 59247973 | - | T | exonic | JUN | frameshift | COAD|1|367|0.00272,COADREAD|1|489|0.00204 |
| - | chr1 | 59248525 | 59248525 | G | A | exonic | JUN | nonsynonymous | CESC|1|194|0.00515 |
| - | chr1 | 59247951 | 59247951 | G | C | exonic | JUN | nonsynonymous | BLCA|2|396|0.00505,LUSC|1|178|0.00562 |
| - | chr1 | 59248305 | 59248305 | C | A | exonic | JUN | synonymous | LUAD|1|543|0.00184 |
| - | chr1 | 59248544 | 59248544 | - | A | exonic | JUN | frameshift | COAD|1|367|0.00272,COADREAD|1|489|0.00204 |
| - | chr1 | 59248076 | 59248076 | G | C | exonic | JUN | nonsynonymous | KIPAN|1|799|0.00125,KIRC|1|451|0.00222 |
| - | chr1 | 59248394 | 59248394 | C | A | exonic | JUN | nonsynonymous | HNSC|1|512|0.00195 |
| - | chr1 | 59248342 | 59248342 | G | T | exonic | JUN | nonsynonymous | STAD|1|395|0.00253,STES|1|395|0.00253 |
| - | chr1 | 59248409 | 59248409 | C | T | exonic | JUN | nonsynonymous | BLCA|3|396|0.00758,BRCA|1|982|0.00102,LUSC|1|178|0.00562 |
| - | chr1 | 59247825 | 59247825 | T | C | exonic | JUN | synonymous | PRAD|1|499|0.00200 |
| - | chr1 | 59248498 | 59248498 | T | - | exonic | JUN | frameshift | BRCA|1|982|0.00102 |
| - | chr1 | 59248443 | 59248443 | G | A | exonic | JUN | synonymous | SARC|1|247|0.00405 |
| - | chr1 | 59247894 | 59247894 | T | G | exonic | JUN | nonsynonymous | UCEC|1|248|0.00403 |
| - | chr1 | 59248200 | 59248200 | C | T | exonic | JUN | synonymous | BLCA|1|396|0.00253 |
| - | chr1 | 59248413 | 59248413 | G | A | exonic | JUN | synonymous | CESC|1|194|0.00515 |
| - | chr1 | 59248539 | 59248539 | C | A | exonic | JUN | synonymous | LUSC|1|178|0.00562 |
| - | chr1 | 59247813 | 59247813 | C | - | exonic | JUN | frameshift | BRCA|1|982|0.00102,STAD|1|395|0.00253,STES|1|395|0.00253 |
| - | chr1 | 59247748 | 59247748 | C | G | exonic | JUN | stoploss | CESC|1|194|0.00515 |
| - | chr1 | 59247823 | 59247823 | T | C | exonic | JUN | nonsynonymous | STAD|1|395|0.00253,STES|1|395|0.00253 |
| - | chr1 | 59248633 | 59248633 | C | A | exonic | JUN | nonsynonymous | SKCM|1|368|0.00272 |
| - | chr1 | 59248101 | 59248101 | C | T | exonic | JUN | synonymous | SKCM|1|368|0.00272 |
| - | chr1 | 59247873 | 59247873 | C | - | exonic | JUN | frameshift | LUAD|2|543|0.00368 |
| - | chr1 | 59248012 | 59248012 | G | A | exonic | JUN | nonsynonymous | LIHC|1|373|0.00268 |
| - | chr1 | 59247894 | 59247894 | T | - | exonic | JUN | frameshift | LUAD|1|543|0.00184 |
| - | chr1 | 59248392 | 59248392 | G | A | exonic | JUN | synonymous | GBM|1|290|0.00345,GBMLGG|1|820|0.00122 |
| - | chr1 | 59248506 | 59248506 | C | G | exonic | JUN | synonymous | BLCA|1|396|0.00253 |
| TF_name | Disease_name | Disease_class | Disease_semantic_type | TF_disease_source |
|---|---|---|---|---|
| JUN | Cholestasis, Extrahepatic | C06 | Disease or Syndrome | CTD_human |
| JUN | Malignant neoplasm of breast | C04;C17 | Neoplastic Process | CTD_human |
| JUN | Malignant tumor of colon | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Neoplastic Cell Transformation | C04;C23 | Neoplastic Process | CTD_human |
| JUN | Brain Ischemia | C10;C14 | Disease or Syndrome | CTD_human |
| JUN | Colonic Neoplasms | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Heat Stroke | C26 | Injury or Poisoning | CTD_human |
| JUN | Hemangiosarcoma | C04 | Neoplastic Process | CTD_human |
| JUN | Hypertensive disease | C14 | Disease or Syndrome | CTD_human |
| JUN | Intestinal Polyps | C23 | Anatomical Abnormality | CTD_human |
| JUN | Liver neoplasms | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Lung Neoplasms | C04;C08 | Neoplastic Process | CTD_human |
| JUN | Malignant neoplasm of stomach | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Osteosarcoma | C04 | Neoplastic Process | CTD_human |
| JUN | Peripheral Neuropathy | C10 | Disease or Syndrome | CTD_human |
| JUN | Reperfusion Injury | C14;C23 | Injury or Poisoning | CTD_human |
| JUN | Schizophrenia | F03 | Mental or Behavioral Dysfunction | PSYGENET |
| JUN | Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Stomach Neoplasms | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Injuries, Acute Brain | C10;C26 | Injury or Poisoning | CTD_human |
| JUN | Minamata Disease | C10;C25 | Injury or Poisoning | CTD_human |
| JUN | Juvenile-Onset Still Disease | C05;C17;C20 | Disease or Syndrome | CTD_human |
| JUN | Malignant neoplasm of lung | C04;C08 | Neoplastic Process | CTD_human |
| JUN | Brain Injuries | C10;C26 | Injury or Poisoning | CTD_human |
| JUN | Petit mal status | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Brain Lacerations | C10;C26 | Injury or Poisoning | CTD_human |
| JUN | Inorganic Mercury Poisoning | C10;C25 | Injury or Poisoning | CTD_human |
| JUN | Mercury Poisoning, Organic | C10;C25 | Injury or Poisoning | CTD_human |
| JUN | Grand Mal Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Malignant neoplasm of liver | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Complex Partial Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Brain Injuries, Focal | C10;C26 | Injury or Poisoning | CTD_human |
| JUN | Mercury Poisoning, Nervous System | C10;C25 | Injury or Poisoning | CTD_human |
| JUN | Breast Carcinoma | C04;C17 | Neoplastic Process | CTD_human |
| JUN | Status Epilepticus, Subclinical | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Non-Convulsive Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Simple Partial Status Epilepticus | C10;C23 | Disease or Syndrome | CTD_human |
| JUN | Mercury Encephalopathy | C10;C25 | Injury or Poisoning | CTD_human |
| JUN | Mad Hatter Disease | C10;C25 | Injury or Poisoning | CTD_human |
| JUN | Mercurial Neuroanesthenia | C10;C25 | Disease or Syndrome | CTD_human |
| JUN | Mercury Psychosis | C10;C25 | Mental or Behavioral Dysfunction | CTD_human |
| JUN | Cerebral Ischemia | C10;C14 | Disease or Syndrome | CTD_human |
| JUN | Mammary Neoplasms, Human | C04;C17 | Neoplastic Process | CTD_human |
| JUN | Sarcoma | C04 | Neoplastic Process | CGI |
| JUN | Mammary Neoplasms | C04;C17 | Neoplastic Process | CTD_human |
| JUN | Hereditary Diffuse Gastric Cancer | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Liver carcinoma | C04;C06 | Neoplastic Process | CTD_human |
| JUN | Juvenile arthritis | C05;C17;C20 | Disease or Syndrome | CTD_human |
| JUN | Juvenile psoriatic arthritis | C05;C17;C20 | Disease or Syndrome | CTD_human |
| pathway_ID | pathway_name | pathway_source | gene_number | edge_number |
|---|---|---|---|---|
| pathway0000080 | Activation of the AP-1 family of transcription factors | reactome | 10 | 35 |
| pathway0000147 | Alpha6Beta4Integrin | netpath | 74 | 899 |
| pathway0000187 | AP-1 transcription factor network | pid | 71 | 659 |
| pathway0000229 | ATF-2 transcription factor network | pid | 59 | 451 |
| pathway0000265 | B cell activation | panther | 52 | 541 |
| pathway0000271 | BCR signaling pathway | pid | 70 | 890 |
| pathway0000343 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | pid | 50 | 304 |
| pathway0000347 | Calcium signaling in the CD4+ TCR pathway | pid | 29 | 153 |
| pathway0000388 | CD40/CD40L signaling | pid | 36 | 298 |
| pathway0000390 | CDC42 signaling events | pid | 71 | 630 |
| pathway0000634 | Downstream signaling in nave CD8+ T cells | pid | 69 | 708 |
| pathway0000669 | Endothelins | pid | 64 | 750 |
| pathway0000692 | ErbB1 downstream signaling | pid | 105 | 1597 |
| pathway0000695 | ErbB2/ErbB3 signaling events | pid | 41 | 404 |
| pathway0000756 | FAS signaling pathway | panther | 37 | 148 |
| pathway0000767 | Fc-epsilon receptor I signaling in mast cells | pid | 64 | 826 |
| pathway0000771 | FCERI mediated MAPK activation | reactome | 40 | 456 |
| pathway0000780 | FGF signaling pathway | pid | 55 | 600 |
| pathway0000824 | FOXA1 transcription factor network | pid | 45 | 204 |
| pathway0000895 | Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) ) | inoh | 5 | 10 |
| pathway0000896 | Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling ) | inoh | 5 | 10 |
| pathway0000916 | Glucocorticoid receptor regulatory network | pid | 85 | 876 |
| pathway0001021 | HIF-1-alpha transcription factor network | pid | 67 | 420 |
| pathway0001114 | IL1-mediated signaling events | pid | 34 | 272 |
| pathway0001115 | IL1 | netpath | 69 | 701 |
| pathway0001117 | IL12 signaling mediated by STAT4 | pid | 33 | 229 |
| pathway0001119 | IL2-mediated signaling events | pid | 54 | 871 |
| pathway0001120 | IL2 | netpath | 81 | 1364 |
| pathway0001130 | IL5 | netpath | 59 | 739 |
| pathway0001131 | IL6-mediated signaling events | pid | 48 | 426 |
| pathway0001132 | IL6 | netpath | 85 | 1335 |
| pathway0001170 | Integrin-linked kinase signaling | pid | 46 | 234 |
| pathway0001194 | Intracellular Signalling Through Adenosine Receptor A2a and Adenosine | smpdb | 37 | 233 |
| pathway0001195 | Intracellular Signalling Through Adenosine Receptor A2b and Adenosine | smpdb | 38 | 237 |
| pathway0001230 | JNK cascade ( CD4 T cell receptor signaling (JNK cascade) ) | inoh | 12 | 48 |
| pathway0001231 | JNK cascade ( CD4 T cell receptor signaling ) | inoh | 10 | 35 |
| pathway0001232 | JNK cascade ( TGF-beta signaling(through TAK1) ) | inoh | 6 | 14 |
| pathway0001233 | JNK cascade ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) ) | inoh | 12 | 45 |
| pathway0001234 | JNK signaling in the CD4+ TCR pathway | pid | 14 | 59 |
| pathway0001246 | KitReceptor | netpath | 104 | 1591 |
| pathway0001295 | LPA receptor mediated events | pid | 65 | 700 |
| pathway0001322 | MAPK6/MAPK4 signaling | reactome | 90 | 1485 |
| pathway0001473 | Nephrin/Neph1 signaling in the kidney podocyte | pid | 28 | 175 |
| pathway0001554 | Osteopontin-mediated events | pid | 32 | 226 |
| pathway0001560 | Oxidative stress response | panther | 23 | 125 |
| pathway0001604 | PDGF signaling pathway | panther | 113 | 1684 |
| pathway0001605 | PDGFR-alpha signaling pathway | pid | 22 | 96 |
| pathway0001606 | PDGFR-beta signaling pathway | pid | 125 | 2449 |
| pathway0001711 | Pre-NOTCH Transcription and Translation | reactome | 29 | 220 |
| pathway0001714 | Presenilin action in Notch and Wnt signaling | pid | 46 | 287 |
| pathway0001727 | Prolactin | netpath | 105 | 1733 |
| pathway0001788 | RAC1 signaling pathway | pid | 54 | 422 |
| pathway0001799 | RANKL | netpath | 84 | 1002 |
| pathway0001805 | Ras Pathway | panther | 69 | 921 |
| pathway0001825 | Regulation of Androgen receptor activity | pid | 54 | 338 |
| pathway0001848 | Regulation of nuclear beta catenin signaling and target gene transcription | pid | 80 | 611 |
| pathway0001849 | Regulation of nuclear SMAD2/3 signaling | pid | 82 | 1072 |
| pathway0001857 | Regulation of retinoblastoma protein | pid | 67 | 718 |
| pathway0001861 | Regulation of Telomerase | pid | 70 | 708 |
| pathway0001903 | RhoA signaling pathway | pid | 46 | 233 |
| pathway0001950 | S1P2 pathway | pid | 26 | 167 |
| pathway0002032 | Signaling events mediated by focal adhesion kinase | pid | 63 | 616 |
| pathway0002036 | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | pid | 80 | 1068 |
| pathway0002043 | Signaling events regulated by Ret tyrosine kinase | pid | 39 | 421 |
| pathway0002044 | Signaling mediated by p38-alpha and p38-beta | pid | 35 | 174 |
| pathway0002069 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | reactome | 32 | 197 |
| pathway0002183 | T cell activation | panther | 60 | 903 |
| pathway0002264 | Toll receptor signaling pathway | panther | 44 | 352 |
| pathway0002273 | TP53 Regulates Transcription of DNA Repair Genes | reactome | 61 | 1425 |
| pathway0002388 | Validated nuclear estrogen receptor alpha network | pid | 65 | 386 |
| pathway0002392 | Validated transcriptional targets of AP1 family members Fra1 and Fra2 | pid | 37 | 165 |
| pathway0002469 | JNK cascade ( IL-1 signaling pathway (through JNK cascade) ) | inoh | 16 | 84 |
| pathway0002471 | JNK cascade ( Toll-like receptor signaling pathway (through JNK cascade) ) | inoh | 12 | 45 |
| pathway0002562 | MAPK signaling pathway | kegg | 264 | 4851 |
| pathway0002564 | ErbB signaling pathway | kegg | 83 | 1425 |
| pathway0002587 | Wnt signaling pathway | kegg | 135 | 1586 |
| pathway0002594 | Focal adhesion | kegg | 197 | 5222 |
| pathway0002602 | Toll-like receptor signaling pathway | kegg | 100 | 1158 |
| pathway0002608 | T cell receptor signaling pathway | kegg | 105 | 1690 |
| pathway0002609 | B cell receptor signaling pathway | kegg | 70 | 856 |
| pathway0002617 | Neurotrophin signaling pathway | kegg | 126 | 2153 |
| pathway0002625 | GnRH signaling pathway | kegg | 98 | 1014 |
| pathway0002646 | Epithelial cell signaling in Helicobacter pylori infection | kegg | 67 | 524 |
| pathway0002649 | Leishmaniasis | kegg | 71 | 594 |
| pathway0002650 | Chagas disease | kegg | 103 | 1158 |
| pathway0002656 | Pathways in cancer | kegg | 321 | 8293 |
| pathway0002657 | Colorectal cancer | kegg | 63 | 642 |
| pathway0002658 | Renal cell carcinoma | kegg | 65 | 609 |
| pathway0002696 | Hs_Apoptosis-related_network_due_to_altered_Notch3_in_ovarian_cancer_WP2864_79278 | wikipathways | 51 | 206 |
| pathway0002717 | Hs_Hepatitis_C_and_Hepatocellular_Carcinoma_WP3646_88640 | wikipathways | 36 | 226 |
| pathway0002719 | Hs_Apoptosis_WP254_88977 | wikipathways | 31 | 127 |
| pathway0002733 | Hs_T-Cell_antigen_Receptor_(TCR)_pathway_during_Staphylococcus_aureus_infection_WP3863_90702 | wikipathways | 35 | 218 |
| pathway0002735 | Hs_PDGF_Pathway_WP2526_82681 | wikipathways | 12 | 44 |
| pathway0002752 | Hs_ATM_Signaling_Pathway_WP2516_90247 | wikipathways | 32 | 187 |
| pathway0002760 | Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 | wikipathways | 44 | 408 |
| pathway0002771 | Hs_BMP_Signaling_Pathway_in_Eyelid_Development_WP3927_90735 | wikipathways | 11 | 21 |
| pathway0002788 | Hs_Nucleotide_Metabolism_WP404_68960 | wikipathways | 16 | 29 |
| pathway0002801 | Hs_TNF_alpha_Signaling_Pathway_WP231_89895 | wikipathways | 61 | 486 |
| pathway0002811 | Hs_Estrogen_signaling_pathway_WP712_78491 | wikipathways | 13 | 57 |
| pathway0002829 | Hs_Kit_receptor_signaling_pathway_WP304_78799 | wikipathways | 46 | 510 |
| pathway0002837 | Hs_IL-5_Signaling_Pathway_WP127_78498 | wikipathways | 35 | 321 |
| pathway0002866 | Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 | wikipathways | 107 | 1336 |
| pathway0002868 | Hs_T-Cell_antigen_Receptor_(TCR)_Signaling_Pathway_WP69_89937 | wikipathways | 60 | 627 |
| pathway0002870 | Hs_IL-1_signaling_pathway_WP195_89932 | wikipathways | 34 | 225 |
| pathway0002871 | Hs_IL-3_Signaling_Pathway_WP286_78583 | wikipathways | 35 | 403 |
| GO_term_name | GO_term_type | TF_name |
|---|---|---|
| GO_POSITIVE_REGULATION_OF_VIRAL_TRANSCRIPTION | BP | JUN |
| GO_SMAD_PROTEIN_SIGNAL_TRANSDUCTION | BP | JUN |
| GO_LABYRINTHINE_LAYER_DEVELOPMENT | BP | JUN |
| GO_MEMBRANE_DEPOLARIZATION | BP | JUN |
| GO_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION | BP | JUN |
| GO_RESPONSE_TO_ORGANOPHOSPHORUS | BP | JUN |
| GO_POSITIVE_REGULATION_OF_NEURON_DEATH | BP | JUN |
| GO_RESPONSE_TO_MUSCLE_STRETCH | BP | JUN |
| GO_RESPONSE_TO_CORTICOSTEROID | BP | JUN |
| GO_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION | BP | JUN |
| GO_CELLULAR_RESPONSE_TO_EXTRACELLULAR_STIMULUS | BP | JUN |
| GO_MYELOID_LEUKOCYTE_DIFFERENTIATION | BP | JUN |
| GO_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION | BP | JUN |
| GO_PROTEIN_IMPORT | BP | JUN |
| GO_RESPONSE_TO_AXON_INJURY | BP | JUN |
| GO_BLASTOCYST_FORMATION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION | BP | JUN |
| GO_LEUKOCYTE_DIFFERENTIATION | BP | JUN |
| GO_AXON_REGENERATION | BP | JUN |
| GO_DECIDUALIZATION | BP | JUN |
| GO_NEGATIVE_REGULATION_OF_DNA_BINDING | BP | JUN |
| GO_PLACENTA_BLOOD_VESSEL_DEVELOPMENT | BP | JUN |
| GO_AGING | BP | JUN |
| GO_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER | BP | JUN |
| GO_POSITIVE_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION | BP | JUN |
| GO_INTRACELLULAR_SIGNAL_TRANSDUCTION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION | BP | JUN |
| GO_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS | BP | JUN |
| GO_MODULATION_OF_TRANSCRIPTION_IN_OTHER_ORGANISM_INVOLVED_IN_SYMBIOTIC_INTERACTION | BP | JUN |
| GO_MYELOID_LEUKOCYTE_ACTIVATION | BP | JUN |
| GO_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE | BP | JUN |
| GO_REPRODUCTIVE_SYSTEM_DEVELOPMENT | BP | JUN |
| GO_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT | BP | JUN |
| GO_REGULATION_OF_SYMBIOSIS_ENCOMPASSING_MUTUALISM_THROUGH_PARASITISM | BP | JUN |
| GO_POSITIVE_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER | BP | JUN |
| GO_REGULATION_OF_DNA_BINDING | BP | JUN |
| GO_RESPONSE_TO_CAMP | BP | JUN |
| GO_REGULATION_OF_FIBROBLAST_PROLIFERATION | BP | JUN |
| GO_RESPONSE_TO_HORMONE | BP | JUN |
| GO_LEARNING | BP | JUN |
| GO_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION | BP | JUN |
| GO_MACROPHAGE_ACTIVATION | BP | JUN |
| GO_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA | BP | JUN |
| GO_RESPONSE_TO_RADIATION | BP | JUN |
| GO_REGULATION_OF_CELL_CYCLE | BP | JUN |
| GO_MICROGLIAL_CELL_ACTIVATION | BP | JUN |
| GO_RESPONSE_TO_ABIOTIC_STIMULUS | BP | JUN |
| GO_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE | BP | JUN |
| GO_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY | BP | JUN |
| GO_OSSIFICATION | BP | JUN |
| GO_MULTI_MULTICELLULAR_ORGANISM_PROCESS | BP | JUN |
| GO_VASCULOGENESIS | BP | JUN |
| GO_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_PROTEIN_COMPLEX_ASSEMBLY | BP | JUN |
| GO_RESPONSE_TO_CORTICOSTERONE | BP | JUN |
| GO_REGULATION_OF_VIRAL_TRANSCRIPTION | BP | JUN |
| GO_NEURON_PROJECTION_REGENERATION | BP | JUN |
| GO_CELLULAR_RESPONSE_TO_CALCIUM_ION | BP | JUN |
| GO_REGULATION_OF_MONOCYTE_DIFFERENTIATION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION | BP | JUN |
| GO_INTERACTION_WITH_SYMBIONT | BP | JUN |
| GO_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION | BP | JUN |
| GO_OSTEOBLAST_DEVELOPMENT | BP | JUN |
| GO_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION | BP | JUN |
| GO_SENSORY_ORGAN_DEVELOPMENT | BP | JUN |
| GO_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS | BP | JUN |
| GO_RESPONSE_TO_MINERALOCORTICOID | BP | JUN |
| GO_TROPHECTODERMAL_CELL_DIFFERENTIATION | BP | JUN |
| GO_OUTFLOW_TRACT_MORPHOGENESIS | BP | JUN |
| GO_MYELOID_CELL_DIFFERENTIATION | BP | JUN |
| GO_REGULATION_OF_PRI_MIRNA_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER | BP | JUN |
| GO_RESPONSE_TO_CYTOKINE | BP | JUN |
| GO_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION | BP | JUN |
| GO_MATERNAL_PLACENTA_DEVELOPMENT | BP | JUN |
| GO_OSTEOCLAST_DIFFERENTIATION | BP | JUN |
| GO_NEGATIVE_REGULATION_OF_TRANSCRIPTION_FROM_RNA_POLYMERASE_II_PROMOTER | BP | JUN |
| GO_NEGATIVE_REGULATION_OF_NEURON_DEATH | BP | JUN |
| GO_RESPONSE_TO_LIGHT_STIMULUS | BP | JUN |
| GO_RESPONSE_TO_MECHANICAL_STIMULUS | BP | JUN |
| GO_APOPTOTIC_MITOCHONDRIAL_CHANGES | BP | JUN |
| GO_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS | BP | JUN |
| GO_RESPONSE_TO_PURINE_CONTAINING_COMPOUND | BP | JUN |
| GO_MONOCYTE_DIFFERENTIATION | BP | JUN |
| GO_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION | BP | JUN |
| GO_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN | BP | JUN |
| GO_RESPONSE_TO_CALCIUM_ION | BP | JUN |
| GO_POSITIVE_REGULATION_OF_OSSIFICATION | BP | JUN |
| GO_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES | BP | JUN |
| GO_NUCLEAR_CHROMOSOME | CC | JUN |
| GO_NUCLEAR_CHROMATIN | CC | JUN |
| GO_TRANSCRIPTION_FACTOR_COMPLEX | CC | JUN |
| GO_NUCLEAR_EUCHROMATIN | CC | JUN |
| GO_EUCHROMATIN | CC | JUN |
| GO_SMAD_BINDING | MF | JUN |
| GO_R_SMAD_BINDING | MF | JUN |
| GO_TRANSCRIPTION_FACTOR_ACTIVITY_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_BINDING | MF | JUN |
| GO_RNA_POLYMERASE_II_TRANSCRIPTION_FACTOR_ACTIVITY_SEQUENCE_SPECIFIC_DNA_BINDING | MF | JUN |
| GO_DOUBLE_STRANDED_DNA_BINDING | MF | JUN |
| GO_HMG_BOX_DOMAIN_BINDING | MF | JUN |
| GO_CAMP_RESPONSE_ELEMENT_BINDING | MF | JUN |
| GO_LIGAND_DEPENDENT_NUCLEAR_RECEPTOR_BINDING | MF | JUN |
| GO_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING | MF | JUN |
| GO_RNA_POLYMERASE_II_ACTIVATING_TRANSCRIPTION_FACTOR_BINDING | MF | JUN |
| GO_RNA_POLYMERASE_II_DISTAL_ENHANCER_SEQUENCE_SPECIFIC_DNA_BINDING | MF | JUN |